3-D Matrix, Ltd. announced that Satoru Kobayashi has been appointed as Director in charge of Business Development, Japan, Takao Miki as Director in charge of EMEA Business, Toshihiko Amanuma as Director in charge of North America Business, Andy Kim as Executive Officer in charge of Asia Oceania Business, Marie Buffier as Executive Officer in charge of R&D, Europe and Lisa Spirio as Executive Officer in charge of R&D, USA.
3-D Matrix, Ltd. is a company engaged in the research, development, manufacture and sale of medical products. The Company has Medical Product segment. The segment consists of two divisions. The medical product development and sales division is engaged in the research and development of medical equipment and drugs for surgery area, regeneration medicine area and drug delivery system (DDS) area based on the self-organizing peptide technology, including hemostatic, vascular embolization and alveolar bone reconstruction materials, among others. The research reagents sales division is engaged in the sale of medical products based on the self-organizing peptide technology for research and test use in universities and research institutes.
3-D MATRIX, LTD. 
